Avastin (bevacizumab)

FDA approves Avastin (bevacizumab) as a first-line treatment for patients with colorectal cancer that has spread to other parts of the body.

• FDA Press Release
• Questions and Answers on Avastin
• Label
• Approval Letter
• Patient Information Sheet

     Back to Drug Info

Date created: February 26, 2004; Updated February 1, 2007

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page

FDA/Center for Drug Evaluation and Research